Bruker–Deutsche Bank: investor conference, 201705 supply service Bruker presents at Deutsche Bank Annual Health Care Conference

	Period	2017-05-04
	Region	Boston, MA
	Country	United States (USA)
	Successor	Bruker–Deutsche Bank: investor conference, 201805 supply service Bruker presents at Deutsche Bank Annual Health Care Conference
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Product	Deutsche Bank Annual Health Care Conference 2017 Boston
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (4/27/17). "Press Release: Bruker Corporation to Present at the 42nd Annual Deutsche Bank Health Care Conference". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 42nd annual Deutsche Bank Health Care Conference at The InterContinental Hotel, 510 Atlantic Avenue, Boston. Frank Laukien, Chairman, President & CEO will participate in a "fireside chat" Q&A session on behalf of the company on Thursday, May 4th, 2017 at 8:40 AM Eastern Time.

A live audio webcast of the presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit: www.bruker.com

Contact:

Miroslava Minkova Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com